ARID1B and cancer: An in vitro study showed that ARID1B is a specific determinant of the SWI/SNF complex, has a broad role in promoting proliferation, and also plays a significant role in inhibiting cell cycle activity, making it an attractive therapeutic target for cancer treatment [19, 42].